首页> 外文期刊>Medicine. >Treatment of obstructive jaundice caused by hepatic artery pseudoaneurysm after liver transplantation: A case report
【24h】

Treatment of obstructive jaundice caused by hepatic artery pseudoaneurysm after liver transplantation: A case report

机译:肝脏移植后肝动脉假肿瘤患者梗阻性黄疸治疗:案例报告

获取原文
           

摘要

Rationale: Despite vast improvements in technique, several complications still challenge surgeons and medical practitioners alike, including biliary and vascular complications, acute and chronic rejection, and disease recurrence. Patient concerns: A 59-year-old man was admitted to hospital on July, 2016. He had hepatitis B cirrhosis related recurrent hepatocellular carcinoma and underwent living donor liver transplantation in our hospital. Diagnosis: At the time of admission, the patient's spirit, diet, sleep, normal urine and stool, and weight did not change significantly. The test indicators are as follows: total bilirubin: 100.1 μmol/L, direct bilirubin: 65.0 μmol/L. Emergency CT in the hospital after admission showed that hepatic artery pseudoaneurysm formation after liver transplantation was observed. Interventions: This patient underwent minimal invasive endovascular treatment. The demographic, clinical, and laboratory data were collected and reviewed. He was treated successfully by endovascular stent grafting and thrombolytic treatment. Outcomes: The blood concentration of tacrolimus (FK506) was 6.3 ng/mL total bilirubin 19.6 μmol/L before discharge. The changing of total bilirubin and direct bilirubin were investigated (Fig. 1). The patient recovered well and was discharged 2 weeks later. The patient is doing well and regularly followed up. Lessons: Coil embolization of aneurysmal sac or placement of a stent graft is a minimally invasive alternative to surgery and definitively excludes a bleeding hepatic artery pseudoaneurysm . This technique can be considered as an effective treatment option for hepatic artery pseudoaneurysm instead of a difficult surgical repair.
机译:理由:尽管技术的巨大改善,但几种并发症仍然挑战外科医生和医疗从业者,包括胆道和血管并发症,急性和慢性排斥,以及疾病复发。患者担忧:2016年7月,一名59岁的人入院。他患有乙型肝炎肝硬化相关的复发性肝细胞癌,并在我们医院接受过生物患者肝脏移植。诊断:在入场时,患者的精神,饮食,睡眠,正常的尿液和粪便,重量没有显着变化。试验指标如下:总胆红素:100.1μmol/ L,直接胆红素:65.0μmol/升。入学后医院中的急诊CT表明,观察到肝移植后的肝动脉伪肿瘤形成。干预措施:该患者接受了最小的侵袭性血管内治疗。收集并审查了人口统计学,临床和实验室数据。他通过血管内支架接枝和溶栓治疗成功治疗。结果:在排出前,凝胶蛋白(FK506)的血液浓度为6.3ng / ml总胆红素19.6μmol/ l。研究了总胆红素和直接胆红素的改变(图1)。患者恢复良好,并在2周后出院。患者做得很好,经常随后随访。课程:线圈栓塞的动脉瘤囊或支架移植物的放置是微创替代的手术,并明确地排除出血性肝动脉伪肿瘤。该技术可以被认为是肝动脉伪肿瘤的有效治疗选择,而不是难以进行手术修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号